February 2014

The latest from Cogstate, leaders in optimizing the measurement of cognition

Groton Maze Learning Test Found To Be Accurate Indicator For Executive Function In Schizophrenia Patients

February 24, 2014

One of the brain’s most important roles is coordinating our daily life through an ongoing series of activities including decision making, planning, reasoning and problem solving. This collection of tasks, known as executive function, is called on when a new situation requires a novel response. It is often this set of cognitive abilities that breaks […]

Controlling Anxiety Symptoms May Slow Cognitive Decline

February 21, 2014

While Alzheimer’s disease is best known as a memory degradation disease, there are often additional symptoms that result from abnormally high levels of beta amyloid, the plaque in the brain that often leads to the disease. Behavioral issues like anxiety, irritability and even depression can affect a patient’s quality of life, sometimes even before a […]

Cogstate Researchers Find That CPAL Test Not Sensitive To Alzheimer’s Treatment

February 17, 2014

In the ongoing search for effective treatments for Alzheimer’s disease, medical researchers need to deal with the ever changing characteristics of each patient’s condition.  Finding a potential therapeutic during a clinical trial requires a cognition metric that can be sensitive to the daily cognitive fluctuations of each patient.  Designing, selecting and administering the right test […]

Demand Grows For Pediatric Cognition Safety Testing Using Cogstate System

February 12, 2014

It is a dilemma faced by parents, physicians and researchers. To find new treatments or medicines for sick children, these same kids often need to be part of clinical research trials. Pharmaceutical companies are required by regulators to collect data on children, and their challenge is to find ways to minimize the time and complexity […]

Gene Variant Linked To Memory Decline In Alzheimer’s Patients

February 3, 2014

As the search for the origins of Alzheimer’s disease intensifies, there is mounting evidence that our genes have a direct effect on our risk level.  While we can’t change our inherited gifts, new research that identifies specific genes may provide an advance warning system that can help us watch for early signs of cognitive decline. […]